Comments

Affimed

AFMDNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$5.12
0.020.39%
At Close: -
$5.01
-0.11-2.15%
After Hours: Jul 25, 9:25 AM EDT
15 minutes delayed
Affimed (AFMD) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$25.00
Lowest Price Target1
$5.00
Consensus Price Target1
$10.67

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Affimed (NASDAQ:AFMD) Stock, Analyst Ratings, Price Targets, Forecasts

Affimed NV has a consensus price target of $10.67 based on the ratings of 10 analysts. The high is $25 issued by Laidlaw & Co. on June 13, 2024. The low is $5 issued by Stifel on April 1, 2024. The 3 most-recent analyst ratings were released by Laidlaw & Co., HC Wainwright & Co., and HC Wainwright & Co. on June 13, 2024, June 13, 2024, and June 3, 2024, respectively. With an average price target of $15 between Laidlaw & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 199.40% upside for Affimed NV from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Apr
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Laidlaw & Co.
HC Wainwright & Co.
Wells Fargo
Stifel
Truist Securities

1calculated from analyst ratings

Analyst Ratings for Affimed

Buy NowGet Alert
06/13/2024Buy Now399%Laidlaw & Co.
Yale Jen
$15 → $25MaintainsBuyGet Alert
06/13/2024Buy Now99.6%HC Wainwright & Co.
Swayampakula Ramakanth
$10 → $10ReiteratesBuy → BuyGet Alert
06/03/2024Buy Now99.6%HC Wainwright & Co.
Swayampakula Ramakanth
$10 → $10ReiteratesBuy → BuyGet Alert
04/01/2024Buy Now399%Wells Fargo
Yanan Zhu
$30 → $25MaintainsOverweightGet Alert
04/01/2024Buy Now—Cantor Fitzgerald
Li Watsek
—Reiterates → OverweightGet Alert
04/01/2024Buy Now-0.2%Stifel
Bradley Canino
$1 → $5MaintainsHoldGet Alert
04/01/2024Buy Now99.6%HC Wainwright & Co.
Swayampakula Ramakanth
$5 → $10MaintainsBuyGet Alert
11/15/2023Buy Now-0.2%HC Wainwright & Co.
Swayampakula Ramakanth
 → $50ReiteratesBuy → BuyGet Alert
11/14/2023Buy Now-40.12%Wells Fargo
Yanan Zhu
$4 → $3MaintainsOverweightGet Alert
09/25/2023Buy Now39.72%Cantor Fitzgerald
Li Watsek
 → $70ReiteratesOverweight → OverweightGet Alert
09/12/2023Buy Now39.72%Cantor Fitzgerald
Li Watsek
 → $70ReiteratesOverweight → OverweightGet Alert
09/07/2023Buy Now39.72%Cantor Fitzgerald
Li Watsek
 → $70ReiteratesOverweight → OverweightGet Alert
08/11/2023Buy Now-20.16%Wells Fargo
Yanan Zhu
$5 → $4MaintainsOverweightGet Alert
08/11/2023Buy Now19.76%Truist Securities
Srikripa Devarakonda
$80 → $60MaintainsBuyGet Alert
08/11/2023Buy Now-0.2%HC Wainwright & Co.
Swayampakula Ramakanth
 → $50ReiteratesBuy → BuyGet Alert
08/08/2023Buy Now19.76%Berenberg
Andy Chen
 → $60Assumes → BuyGet Alert
06/05/2023Buy Now-0.2%HC Wainwright & Co.
Swayampakula Ramakanth
$60 → $50MaintainsBuyGet Alert
05/25/2023Buy Now-0.2%Wells Fargo
Yanan Zhu
$7 → $5MaintainsOverweightGet Alert
05/24/2023Buy Now19.76%HC Wainwright & Co.
Swayampakula Ramakanth
 → $60ReiteratesBuy → BuyGet Alert
03/27/2023Buy Now39.72%Wells Fargo
Yanan Zhu
 → $70Assumes → OverweightGet Alert
03/24/2023Buy Now-80.04%Stifel
Bradley Canino
$20 → $10MaintainsHoldGet Alert
03/24/2023Buy Now19.76%HC Wainwright & Co.
Swayampakula Ramakanth
 → $60Reiterates → BuyGet Alert
12/12/2022Buy Now39.72%Wells Fargo
James Shin
$80 → $70MaintainsOverweightGet Alert
12/12/2022Buy Now19.76%Piper Sandler
Do Kim
$70 → $60MaintainsOverweightGet Alert
12/12/2022Buy Now19.76%SVB Leerink
Daina Graybosch
$100 → $60MaintainsOutperformGet Alert
12/12/2022Buy Now19.76%HC Wainwright & Co.
Swayampakula Ramakanth
 → $60Initiates → BuyGet Alert
10/10/2022Buy Now-60.08%Stifel
Bradley Canino
$90 → $20DowngradeBuy → HoldGet Alert
06/23/2022Buy Now79.64%SVB Leerink
Daina Graybosch
$100 → $90MaintainsOutperformGet Alert
03/31/2022Buy Now39.72%Piper Sandler
Do Kim
 → $70Initiates → OverweightGet Alert
02/23/2022Buy Now139.52%Cantor Fitzgerald
Li Watsek
 → $120Initiates → OverweightGet Alert
10/21/2021Buy Now99.6%Truist Securities
Srikripa Devarakonda
 → $100Initiates → BuyGet Alert
10/12/2021Buy Now139.52%SVB Leerink
Daina Graybosch
$130 → $120MaintainsOutperformGet Alert
09/30/2021Buy Now139.52%Stifel
Bradley Canino
 → $120Initiates → BuyGet Alert

FAQ

Q

What is the target price for Affimed (AFMD) stock?

A

The latest price target for Affimed (NASDAQ:AFMD) was reported by Laidlaw & Co. on June 13, 2024. The analyst firm set a price target for $25.00 expecting AFMD to rise to within 12 months (a possible 399.00% upside). 16 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Affimed (AFMD)?

A

The latest analyst rating for Affimed (NASDAQ:AFMD) was provided by Laidlaw & Co., and Affimed maintained their buy rating.

Q

When was the last upgrade for Affimed (AFMD)?

A

There is no last upgrade for Affimed

Q

When was the last downgrade for Affimed (AFMD)?

A

The last downgrade for Affimed NV happened on October 10, 2022 when Stifel changed their price target from $9 to $2 for Affimed NV.

Q

When is the next analyst rating going to be posted or updated for Affimed (AFMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Affimed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Affimed was filed on June 13, 2024 so you should expect the next rating to be made available sometime around June 13, 2025.

Q

Is the Analyst Rating Affimed (AFMD) correct?

A

While ratings are subjective and will change, the latest Affimed (AFMD) rating was a maintained with a price target of $15.00 to $25.00. The current price Affimed (AFMD) is trading at is $5.01, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.